Microba Life Sciences Limited
ASX:MAP.AX
0.17 (AUD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue
| 12.09 | 5.42 | 4.689 | 3.732 | 2.909 | 1.828 |
| Cost of Revenue
| 6.185 | 12.193 | 2.323 | 9.037 | 6.962 | 4.318 |
| Gross Profit
| 5.905 | -6.773 | 2.366 | -5.305 | -4.053 | -2.49 |
| Gross Profit Ratio
| 0.488 | -1.25 | 0.505 | -1.421 | -1.393 | -1.362 |
| Reseach & Development Expenses
| 10.836 | 9.337 | 5.384 | 1.539 | 0.163 | 0 |
| General & Administrative Expenses
| 12.179 | 7.809 | 8.573 | 0.822 | 1.977 | 1.1 |
| Selling & Marketing Expenses
| 0.786 | 0.693 | 0.541 | 0.338 | 0.225 | 0.318 |
| SG&A
| 12.965 | 4.12 | 9.114 | 2.726 | 3.19 | 2.299 |
| Other Expenses
| 8.947 | 0.003 | 4.817 | 0 | 0 | 0 |
| Operating Expenses
| 32.748 | 13.454 | 18.638 | 4.266 | 3.353 | 2.299 |
| Operating Income
| -26.843 | -20.227 | -11.453 | -9.57 | -7.406 | -4.789 |
| Operating Income Ratio
| -2.22 | -3.732 | -2.443 | -2.564 | -2.546 | -2.62 |
| Total Other Income Expenses Net
| 6.853 | 1.458 | 4.817 | 2.047 | 0.749 | 0.068 |
| Income Before Tax
| -19.99 | -18.769 | -11.461 | -7.524 | -6.657 | -4.721 |
| Income Before Tax Ratio
| -1.653 | -3.463 | -2.444 | -2.016 | -2.288 | -2.582 |
| Income Tax Expense
| -0.051 | -6.089 | 0.009 | 0 | -0.007 | 0.013 |
| Net Income
| -19.938 | -12.68 | -11.47 | -7.524 | -6.651 | -4.734 |
| Net Income Ratio
| -1.649 | -2.339 | -2.446 | -2.016 | -2.286 | -2.589 |
| EPS
| -0.049 | -0.038 | -0.04 | -0.026 | -0.023 | -0.016 |
| EPS Diluted
| -0.049 | -0.038 | -0.04 | -0.026 | -0.023 | -0.016 |
| EBITDA
| -17.101 | -18.585 | -9.91 | -8.352 | -6.315 | -4.024 |
| EBITDA Ratio
| -1.414 | -3.429 | -2.114 | -2.238 | -2.171 | -2.201 |